JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist
  • 8701.0
  • +47.0+0.54%
20min DelayMarket Closed Apr 25 15:30 JST
696.09BMarket Cap28.19P/E (Static)

COSMOS Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Feb 28, 2025
(Q1)Aug 31, 2024
(FY)May 31, 2024
(Q4)May 31, 2024
(Q3)Feb 29, 2024
(Q2)Nov 30, 2023
(Q1)Aug 31, 2023
(FY)May 31, 2023
(Q4)May 31, 2023
(Q3)Feb 28, 2023
Total revenue
3.12%246.33B
8.35%261.84B
16.59%964.99B
12.77%249.68B
18.09%238.88B
18.64%234.78B
17.24%241.65B
9.57%827.7B
12.65%221.4B
7.74%202.29B
Cost of revenue
0.55%193.2B
6.49%207.28B
17.86%776.68B
13.59%201.04B
19.21%192.15B
20.31%188.86B
18.81%194.64B
9.11%658.98B
13.07%176.99B
7.11%161.19B
Gross profit
13.70%53.13B
16.06%54.56B
11.61%188.31B
9.53%48.64B
13.72%46.73B
12.21%45.92B
11.16%47.01B
11.40%168.72B
11.04%44.41B
10.30%41.1B
Operating expense
7.77%41.85B
13.05%42.98B
13.14%156.8B
12.16%40.88B
13.16%38.83B
13.47%39.07B
13.86%38.02B
13.92%138.59B
13.56%36.45B
13.10%34.32B
Operating profit
42.80%11.28B
28.80%11.58B
4.55%31.5B
-2.51%7.76B
16.53%7.9B
5.55%6.85B
1.02%8.99B
1.12%30.13B
0.81%7.96B
-1.99%6.78B
Net non-operating interest income (expenses)
-466.67%-34M
-375.00%-38M
-1,275.00%-55M
-600.00%-35M
-700.00%-6M
-700.00%-6M
-700.00%-8M
-4M
-350.00%-5M
1M
Non-operating interest income
16.67%14M
10.00%11M
-6.38%44M
-8.33%11M
0.00%12M
-8.33%11M
-9.09%10M
-9.62%47M
-14.29%12M
-7.69%12M
Non-operating interest expense
166.67%48M
172.22%49M
94.12%99M
170.59%46M
63.64%18M
54.55%17M
50.00%18M
-1.92%51M
41.67%17M
-15.38%11M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
-255.56%-252M
-268.85%-225M
-86.17%-579M
-300.66%-609M
723.08%162M
21.11%-71M
-41.86%-61M
-266.31%-311M
-38.18%-152M
-116.88%-26M
Less:Restructuring and mergern&acquisition
--0
-25.93%20M
-63.49%69M
-63.83%51M
-311.11%-19M
-58.33%10M
80.00%27M
20.38%189M
95.83%141M
-79.07%9M
Less:Other special charges
276.22%252M
502.94%205M
-120.49%-25M
109.09%23M
-941.18%-143M
-7.58%61M
21.43%34M
135.47%122M
-71.05%11M
108.63%17M
Less:Write off
----
----
--535M
----
----
----
----
--0
----
----
Other non-operating income (expenses)
10.86%745M
5.03%751M
-3.61%2.85B
-10.34%659M
-5.35%672M
2.28%807M
-1.52%715M
-3.46%2.96B
-14.83%735M
3.35%710M
Income before tax
34.53%11.74B
25.22%12.07B
2.89%33.72B
-8.95%7.78B
16.89%8.73B
5.49%7.58B
0.57%9.64B
-0.83%32.77B
-1.27%8.54B
-3.78%7.47B
Income tax
29.37%3.83B
25.38%3.92B
3.23%9.27B
-33.69%681M
19.17%2.96B
5.54%2.5B
0.94%3.13B
-9.27%8.98B
-47.33%1.03B
-2.70%2.48B
Net income
37.18%7.92B
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
Net income continuous operations
37.18%7.92B
25.14%8.14B
2.76%24.45B
-5.56%7.1B
15.75%5.77B
5.46%5.08B
0.40%6.51B
2.77%23.8B
12.13%7.51B
-4.30%4.99B
Noncontrolling interests
Net income attributable to the company
37.18%7.92B
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
37.18%7.92B
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
Gross dividend payment
Basic earnings per share
37.17%99.86
25.03%102.74
2.71%308.61
-5.62%89.54
15.67%72.8
5.37%64.095
0.41%82.175
2.77%300.48
12.14%94.87
-4.32%62.94
Diluted earnings per share
37.17%99.86
25.03%102.74
2.71%308.61
-5.62%89.54
15.68%72.8
5.35%64.0821
0.41%82.175
2.77%300.48
12.14%94.87
-4.34%62.931
Dividend per share
0
0
20.00%60
4.35%30
0
41.18%30
0
25.00%50
43.75%28.75
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Feb 28, 2025(Q1)Aug 31, 2024(FY)May 31, 2024(Q4)May 31, 2024(Q3)Feb 29, 2024(Q2)Nov 30, 2023(Q1)Aug 31, 2023(FY)May 31, 2023(Q4)May 31, 2023(Q3)Feb 28, 2023
Total revenue 3.12%246.33B8.35%261.84B16.59%964.99B12.77%249.68B18.09%238.88B18.64%234.78B17.24%241.65B9.57%827.7B12.65%221.4B7.74%202.29B
Cost of revenue 0.55%193.2B6.49%207.28B17.86%776.68B13.59%201.04B19.21%192.15B20.31%188.86B18.81%194.64B9.11%658.98B13.07%176.99B7.11%161.19B
Gross profit 13.70%53.13B16.06%54.56B11.61%188.31B9.53%48.64B13.72%46.73B12.21%45.92B11.16%47.01B11.40%168.72B11.04%44.41B10.30%41.1B
Operating expense 7.77%41.85B13.05%42.98B13.14%156.8B12.16%40.88B13.16%38.83B13.47%39.07B13.86%38.02B13.92%138.59B13.56%36.45B13.10%34.32B
Operating profit 42.80%11.28B28.80%11.58B4.55%31.5B-2.51%7.76B16.53%7.9B5.55%6.85B1.02%8.99B1.12%30.13B0.81%7.96B-1.99%6.78B
Net non-operating interest income (expenses) -466.67%-34M-375.00%-38M-1,275.00%-55M-600.00%-35M-700.00%-6M-700.00%-6M-700.00%-8M-4M-350.00%-5M1M
Non-operating interest income 16.67%14M10.00%11M-6.38%44M-8.33%11M0.00%12M-8.33%11M-9.09%10M-9.62%47M-14.29%12M-7.69%12M
Non-operating interest expense 166.67%48M172.22%49M94.12%99M170.59%46M63.64%18M54.55%17M50.00%18M-1.92%51M41.67%17M-15.38%11M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) -255.56%-252M-268.85%-225M-86.17%-579M-300.66%-609M723.08%162M21.11%-71M-41.86%-61M-266.31%-311M-38.18%-152M-116.88%-26M
Less:Restructuring and mergern&acquisition --0-25.93%20M-63.49%69M-63.83%51M-311.11%-19M-58.33%10M80.00%27M20.38%189M95.83%141M-79.07%9M
Less:Other special charges 276.22%252M502.94%205M-120.49%-25M109.09%23M-941.18%-143M-7.58%61M21.43%34M135.47%122M-71.05%11M108.63%17M
Less:Write off ----------535M------------------0--------
Other non-operating income (expenses) 10.86%745M5.03%751M-3.61%2.85B-10.34%659M-5.35%672M2.28%807M-1.52%715M-3.46%2.96B-14.83%735M3.35%710M
Income before tax 34.53%11.74B25.22%12.07B2.89%33.72B-8.95%7.78B16.89%8.73B5.49%7.58B0.57%9.64B-0.83%32.77B-1.27%8.54B-3.78%7.47B
Income tax 29.37%3.83B25.38%3.92B3.23%9.27B-33.69%681M19.17%2.96B5.54%2.5B0.94%3.13B-9.27%8.98B-47.33%1.03B-2.70%2.48B
Net income 37.18%7.92B25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B
Net income continuous operations 37.18%7.92B25.14%8.14B2.76%24.45B-5.56%7.1B15.75%5.77B5.46%5.08B0.40%6.51B2.77%23.8B12.13%7.51B-4.30%4.99B
Noncontrolling interests
Net income attributable to the company 37.18%7.92B25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 37.18%7.92B25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B
Gross dividend payment
Basic earnings per share 37.17%99.8625.03%102.742.71%308.61-5.62%89.5415.67%72.85.37%64.0950.41%82.1752.77%300.4812.14%94.87-4.32%62.94
Diluted earnings per share 37.17%99.8625.03%102.742.71%308.61-5.62%89.5415.68%72.85.35%64.08210.41%82.1752.77%300.4812.14%94.87-4.34%62.931
Dividend per share 0020.00%604.35%30041.18%30025.00%5043.75%28.750
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Market Hot Picks Market Hot Picks
No. Symbol Price
Metaplanet
3350
335
Nissan Motor
7201
335.0
Shin-Etsu Chemical
4063
4046.0
4
Nidec
6594
2510.5
5
Advantest
6857
6000.0
Log In for the Full List
Unlock Now